WUH: A phase 3 long term open-label trial investigating safety and efficacy of Transcon hGH administered once weekly in children with growth hormone deficiency (GHD) who have completed a prior Transcon hGH trial.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Growth Hormone Deficiency
  • Age: Between 3 - 12 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Children who have completed a prior phase 3 TransCon hGH trial
    2. Children who have not permanently discontinued study drug in the prior trial
    3. Written, signed, informed consent of the parent or legal guardian of the subject and written assent of the subject as required by the institutional review board/human research ethics committee/independent ethics committee (IRB/HREC/IEC)

You may not be eligible for this study if the following are true:

    1. Poorly-controlled diabetes mellitus (HbA1c = 8.0%) or diabetic complications
    2. Evidence of closed epiphyses, defined as bone age > 14.0 years for females or > 16.0 years for males
    3. Major medical conditions unless approved by Medical Expert
    4. Known hypersensitivity to the components of the trial medication
    5. Likely to be non-compliant with respect to trial conduct (inregards to the subject and/or the parent/legal guardian/caregiver)
    6. Pregnancy
    7. Any other reason that in the opinion of the investigator would prevent the subject from completing participation or following the trial schedule

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.